Breakthrough in lipedema: liposuction now covered by health insurance!

Breakthrough in lipedema: liposuction now covered by health insurance!

The Federal Joint Committee (GBA) has made an important decision: Liposuction, also known as liposuction, is now recognized as a standard service by statutory health insurance companies. This particularly applies to the treatment of lipedema patients, a disease that almost exclusively affects women and is associated with painful fat accumulations in the legs and arms. As maz-online.de reports, this decision is based on the results of the LIPLEG study, which are clear Proven advantages of surgical treatment over conservative therapies.

The implications of this decision are extremely significant for affected women, as the diagnosis of lipedema often represents a long odyssey. According to experts, it usually takes seven to ten years for the disease to be diagnosed because there is no biological marker and the diagnosis is usually clinical. Hormones and genetic factors play a role here. Conservative therapy, which includes things like compression stockings and exercise therapy, often does not have the desired impact on patients' quality of life. Therefore, surgical liposuction, which may require multiple procedures, is now a ray of hope for many.

New guidelines for treatment

What is particularly noteworthy is that liposuction is now also approved for patients' arms. The previous requirements, according to which this treatment was only approved as a health insurance benefit in advanced stage III, have been revised. Specific criteria now apply to the reimbursement of costs: The diagnosis must be made according to a four-eye principle, the body weight must remain stable or be reduced over a period of six months and it must be proven that the conservative therapies were not sufficient.

Dr. Mojtaba Ghods, chief physician at the Clinic for Plastic, Aesthetic and Reconstructive Microsurgery at the Ernst von Bergmann Clinic and a pioneer in lipedema research, was significantly involved in the LIPLEG study. He emphasizes the importance of these developments for patients: “We are pleased that women now have access to effective therapy, regardless of their financial situation.” This is evident in the results of the LIPLEG study, which showed a significant improvement in the quality of life of patients who underwent liposuction. This study included 450 patients and represents an important basis for current decisions.

A look into the future

The increase in surgical measures could also have a positive impact on research into the disease. Current projects aim to find a diagnostic biomarker for lipedema and possibly develop drug therapies. Until now, there have been only limited options for the medical treatment of lipedema. These new developments could help to significantly improve the quality of life of those affected.

Publication of the reimbursement decision is expected in October, and many hope it will usher in a new era in the treatment of lipedema. However, patient representatives are already expressing concerns about some details of the quality assurance guidelines and the required limit values.

In any case, those affected are looking forward to an improved supply situation because they now have the opportunity to sustainably relieve pain and discomfort and make their everyday lives significantly easier. A positive development that shows that patients' voices have been heard and medical research is finally finding its place in the healthcare system.

For further information on changes in health insurance benefits, see the reports presseportal.de and aok.de.